The Effect of Mandibular Advancement With Clear Aligners on Maxillary and Mandibular Volumes
NCT ID: NCT07056829
Last Updated: 2025-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
55 participants
INTERVENTIONAL
2025-05-01
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In recent years, clear aligner systems have become increasingly popular in orthodontic practice. A mandibular advancement feature was recently integrated into these aligners, allowing for simultaneous tooth alignment and forward positioning of the lower jaw. In this study, the newly developed Mandibular Advancement Appliance (MAA), based on clear aligners, will be compared to the traditional functional appliance known as the Activator.
Who Can Participate in the Study? Children with retrusive lower jaws who are in the growth and development period Individuals with no prior orthodontic treatment Patients with specific levels of dental protrusion (overjet) Those with good general health and no contraindications for CBCT imaging What Will the Treatment Process Involve?
Participants will be randomly assigned to one of three groups:
MAA group (clear aligners with mandibular advancement) Activator group (traditional removable appliance) Control group (no treatment, only observation) The active treatment period will last approximately 7-8 months, followed by a retention phase. All patients will be monitored regularly, and strict adherence to appliance use will be expected.
How Will the Outcomes Be Assessed? Before and after the treatment period, participants will undergo cone-beam computed tomography (CBCT) scans to obtain detailed three-dimensional images of the jaws. These images will be analyzed to evaluate volumetric changes. All measurements will be performed by a trained orthodontic specialist using dedicated software.
Potential Benefits for Participants:
Participants will receive close clinical monitoring throughout the study period. The use of advanced imaging technologies may support the development of more effective and individualized treatment plans.
Safety and Confidentiality:
This study has received ethical approval and will be conducted in accordance with relevant data protection and research ethics standards. All personal data will be kept confidential. Written informed consent will be obtained from all participants and/or their legal guardians.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Effect of Clear Aligner Mandibular Advancement and Twin Block Appliances in Class II Malocclusion
NCT06609733
Comparison of Skeletal Effects of Herbst and Invisalign MA in Growing Patients With KLass II Malocclusion
NCT06409923
Treating Growing Patients With Mandibular Prognathism and Maxillary Constriction
NCT06762418
The Effectiveness of the Twin Block and Carriere Motion Appliances in Post-pubertal Patients and an Evaluation of the Impact of Class II Malocclusion and Its Correction on Oral Health-related Quality of Life
NCT07292636
Effects of Open Bite Activator and Skeletal Anchorage-Supported Vertical Elastics on the Masseter Muscle
NCT06949527
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MAA Group
Patients receive orthodontic treatment using clear aligners (Invisalign) with integrated mandibular advancement features (MAA). Advancement is performed in 2 mm increments every 8 weeks over \~8 months.
Mandibular Advancement Appliance (Invisalign MA)
Clear aligner system with integrated buccal precision wings to posture the mandible forward.
Advancement protocol: 2 mm increments every 8 weeks. Total active treatment duration: \~8.15 months, followed by retention phase. Patients instructed to wear aligners ≥20 h/day, removing only for eating and oral hygiene.
Activator Group
Patients receive traditional removable functional appliance therapy (Activator) for \~7 months.
Activator Appliance
Traditional removable functional appliance fabricated on a standardized bite registration.
Patients instructed to wear appliance 24 h/day except during meals and sports. Total active treatment duration: \~7.15 months, followed by retention phase.
Control Group
Patients receive no orthodontic treatment but are monitored for the same duration as the treatment groups.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mandibular Advancement Appliance (Invisalign MA)
Clear aligner system with integrated buccal precision wings to posture the mandible forward.
Advancement protocol: 2 mm increments every 8 weeks. Total active treatment duration: \~8.15 months, followed by retention phase. Patients instructed to wear aligners ≥20 h/day, removing only for eating and oral hygiene.
Activator Appliance
Traditional removable functional appliance fabricated on a standardized bite registration.
Patients instructed to wear appliance 24 h/day except during meals and sports. Total active treatment duration: \~7.15 months, followed by retention phase.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Bilateral full or half cusp Class II molar relationship
* Skeletal Class II relationship associated with mandibular retrognathia (ANB angle \> 4° and SNB angle \< 78°)
* Horizontal or average growth pattern (SN-GoGn ≤ 38°)
* Overjet distance between +4 mm and +8 mm; (6) Good patient compliance throughout the treatment.
Exclusion Criteria
* Presence of maxillary prognathism
* High-angle growth pattern (SN-GoGn \> 38°)
* Transverse orthodontic anomalies or facial asymmetry
* Palpation-induced tenderness or pain in the masticatory muscles
* Presence of clicking, crepitus, pain, or tenderness in the temporomandibular joint (TMJ)
* Congenital or acquired craniofacial deformities
* Poor patient compliance or oral hygiene
* Any condition that could interfere with CBCT imaging.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Batman University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nursezen Kavasoglu
Assistant Professor Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Batman University Faculty of Dentistry
Batman, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NK02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.